Kiniciti

Kiniciti is a New York-based buy-and-build platform that invests in and scales non-therapeutic service, tools, and technology companies enabling cell and gene therapy (CGT) innovation. The firm provides capital, commercial expertise, and strategic resources to its portfolio companies, focusing on industrializing CGT support services for global drug developers. Backed by private equity investments from Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners, Kiniciti operates with an estimated 11-50 employees. Its portfolio includes Ncardia and Cellistic, with an advisory board featuring industry figures like Denis Bedoret and Andrew Knudten. Kiniciti was founded in 2021 by co-founders Geoffrey Glass and Jason Connor. Its business model centers on backed by private equity investments from WCAS and Biospring Partners, acquires and scales CGT-enabling companies as a platform.